BONYF NV Expands into the U.S. Market with Strategic Partnership

In a significant move that marks a new chapter in its growth strategy, BONYF NV has announced its first exports to the United States, partnering with Honest Pharma. This development, announced on May 15, 2025, signifies a pivotal moment for the Belgian-based company, known for its innovative oral and dental care products. The partnership with Honest Pharma, a U.S.-based healthcare company supported by the reputable investor group Investment 360, underscores BONYF NV’s commitment to expanding its global footprint and meeting the increasing demand for high-quality oral care solutions.

A Milestone in U.S. Expansion

BONYF NV, with its primary exchange on the NYSE Euronext Paris and a market capitalization of 10,123,920 EUR, has long been a leader in the dental consumer goods and professional dental consumables sector. The company’s strategic move to enter the U.S. market through exports is a testament to its ambition and the global appeal of its products. The announcement was made from Knokke-Heist, Belgium, highlighting the company’s international reach and its dedication to bringing Swiss-quality products to a broader audience.

Innovative Products Meet U.S. Standards

Central to this expansion are two of BONYF NV’s proprietary products, both developed and produced in Switzerland. These products have successfully met the stringent requirements set by the U.S. Food and Drug Administration (FDA), ensuring they adhere to the highest standards of quality and safety. The first product is a next-generation denture fixative cream, notable for its formulation with 30% organic olive oil. This innovative product promises up to 24 hours of secure denture fixation, offering a blend of efficacy and natural ingredients that cater to the growing consumer preference for organic and sustainable products.

Strategic Partnership with Honest Pharma

The collaboration with Honest Pharma is a strategic choice for BONYF NV, leveraging Honest Pharma’s established presence in the U.S. healthcare market and its backing by Investment 360. This partnership not only facilitates BONYF NV’s entry into the U.S. market but also aligns with its vision of providing differentiated oral care products that meet the needs of consumers worldwide. Through this alliance, BONYF NV’s products are now accessible to leading dental professionals and specialty retailers across the United States, marking a significant step in the company’s international expansion efforts.

Looking Ahead

As BONYF NV embarks on this new phase of growth, the successful launch of its first exports to the United States represents more than just a business milestone; it reflects the company’s ongoing commitment to innovation, quality, and global expansion. With a focus on meeting the evolving needs of consumers and professionals in the oral care sector, BONYF NV is well-positioned to strengthen its presence in the U.S. market and beyond, promising exciting developments in the years to come.